MIBiG 3.0: a community-driven effort to annotate experimentally validated biosynthetic gene clusters.
Terlouw BR, Blin K, Navarro-Muñoz JC, Avalon NE, Chevrette MG, Egbert S, Lee S, Meijer D, Recchia MJJ, Reitz ZL, van Santen JA, Selem-Mojica N, Tørring T, Zaroubi L, Alanjary M, Aleti G, Aguilar C, Al-Salihi SAA, Augustijn HE, Avelar-Rivas JA, Avitia-Domínguez LA, Barona-Gómez F, Bernaldo-Agüero J, Bielinski VA, Biermann F, Booth TJ, Carrion Bravo VJ, Castelo-Branco R, Chagas FO, Cruz-Morales P, Du C, Duncan KR, Gavriilidou A, Gayrard D, Gutiérrez-García K, Haslinger K, Helfrich EJN, van der Hooft JJJ, Jati AP, Kalkreuter E, Kalyvas N, Kang KB, Kautsar S, Kim W, Kunjapur AM, Li YX, Lin GM, Loureiro C, Louwen JJR, Louwen NLL, Lund G, Parra J, Philmus B, Pourmohsenin B, Pronk LJU, Rego A, Rex DAB, Robinson S, Rosas-Becerra LR, Roxborough ET, Schorn MA, Scobie DJ, Singh KS, Sokolova N, Tang X, Udwary D, Vigneshwari A, Vind K, Vromans SPJM, Waschulin V, Williams SE, Winter JM, Witte TE, Xie H, Yang D, Yu J, Zdouc M, Zhong Z, Collemare J, Linington RG, Weber T, Medema MH. · 2023
Read MIBiG 3.0: a community-driven effort to annotate experimentally validated biosynthetic gene clusters. by Terlouw BR, Blin K, Navarro-Muñoz JC, Avalon NE, Chevrette MG, Egbert S, Lee S, Meijer D, Recchia MJJ, Reitz ZL, van Santen JA, Selem-Mojica N, Tørring T, Zaroubi L, Alanjary M, Aleti G, Aguilar C, Al-Salihi SAA, Augustijn HE, Avelar-Rivas JA, Avitia-Domínguez LA, Barona-Gómez F, Bernaldo-Agüero J, Bielinski VA, Biermann F, Booth TJ, Carrion Bravo VJ, Castelo-Branco R, Chagas FO, Cruz-Morales P, Du C, Duncan KR, Gavriilidou A, Gayrard D, Gutiérrez-García K, Haslinger K, Helfrich EJN, van der Hooft JJJ, Jati AP, Kalkreuter E, Kalyvas N, Kang KB, Kautsar S, Kim W, Kunjapur AM, Li YX, Lin GM, Loureiro C, Louwen JJR, Louwen NLL, Lund G, Parra J, Philmus B, Pourmohsenin B, Pronk LJU, Rego A, Rex DAB, Robinson S, Rosas-Becerra LR, Roxborough ET, Schorn MA, Scobie DJ, Singh KS, Sokolova N, Tang X, Udwary D, Vigneshwari A, Vind K, Vromans SPJM, Waschulin V, Williams SE, Winter JM, Witte TE, Xie H, Yang D, Yu J, Zdouc M, Zhong Z, Collemare J, Linington RG, Weber T, Medema MH. (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc9825592.txt.
Introduction
Terlouw and co-authors present the third MIBiG release, a community effort to annotate biosynthetic gene clusters. Gene clusters build nature's drug like compounds in microbes and plants. Genome mining hunts those clusters for new medicines. A shared standard makes cluster records comparable worldwide.
The standard and database both date back to 2015. This release rechecked and re-annotated the older entries. It added 661 new cluster entries to the store. Compound structures got special care in the pass. Biological activities of the products were annotated too. Protein domain choices within clusters were refined. Crowd curation drives much of the entry work. Mass online annotathons powered the validation drive. The data are free for all users to take. The authors pitch the set as training gold. Learning models can learn cluster to compound rules from it.
Catalog record
| CREATOR | Terlouw BR, Blin K, Navarro-Muñoz JC, Avalon NE, Chevrette MG, Egbert S, Lee S, Meijer D, Recchia MJJ, Reitz ZL, van Santen JA, Selem-Mojica N, Tørring T, Zaroubi L, Alanjary M, Aleti G, Aguilar C, Al-Salihi SAA, Augustijn HE, Avelar-Rivas JA, Avitia-Domínguez LA, Barona-Gómez F, Bernaldo-Agüero J, Bielinski VA, Biermann F, Booth TJ, Carrion Bravo VJ, Castelo-Branco R, Chagas FO, Cruz-Morales P, Du C, Duncan KR, Gavriilidou A, Gayrard D, Gutiérrez-García K, Haslinger K, Helfrich EJN, van der Hooft JJJ, Jati AP, Kalkreuter E, Kalyvas N, Kang KB, Kautsar S, Kim W, Kunjapur AM, Li YX, Lin GM, Loureiro C, Louwen JJR, Louwen NLL, Lund G, Parra J, Philmus B, Pourmohsenin B, Pronk LJU, Rego A, Rex DAB, Robinson S, Rosas-Becerra LR, Roxborough ET, Schorn MA, Scobie DJ, Singh KS, Sokolova N, Tang X, Udwary D, Vigneshwari A, Vind K, Vromans SPJM, Waschulin V, Williams SE, Winter JM, Witte TE, Xie H, Yang D, Yu J, Zdouc M, Zhong Z, Collemare J, Linington RG, Weber T, Medema MH. |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
MIBiG 3.0: a community-driven effort to annotate experimentally validated biosynthetic gene clusters By Barbara R Terlouw, Kai Blin, Jorge C Navarro-Muñoz, Nicole E Avalon, Marc G Chevrette, Susan Egbert, Sanghoon Lee, David Meijer, Michael J J Recchia, Zachary L Reitz, Jeffrey A van Santen, Nelly Selem-Mojica Published in: Nucleic Acids Research DOI: 10.1093/nar/gkac1049 ABSTRACT Abstract With an ever-increasing amount of (meta)genomic data being deposited in sequence databases, (meta)genome mining for natural product biosynthetic pathways occupies a critical role in the discovery of novel pharmaceutical drugs, crop protection agents and biomaterials. The genes that encode these pathways are often organised into biosynthetic gene clusters (BGCs). In 2015, we defined the Minimum Information about a Biosynthetic Gene cluster (MIBiG): a standardised data format that describes the minimally required information to uniquely characterise a BGC. We simultaneously constructed an accompanying online database of BGCs, which has since been widely used by the community as a reference dataset for BGCs and was expanded to 2021 entries in 2019 (MIBiG 2.0). Here, we describe MIBiG 3.0, a database update comprising large-scale validation and re-annotation of existing entries and 661 new entries. Particular attention was paid to the annotation of compound structures and biological activities, as well as protein domain selectivities. Together, these new features keep the database up-to-date, and will provide new opportunities for the scientific community to use its freely available data, e.g. for the training of new machine learning models to predict sequence-structure-function relationships for diverse natural products. MIBiG 3.0 is accessible online at https://mibig.secondarymetabolites.org/. INTRODUCTION Across all kingdoms of life, organisms produce specialised metabolites: molecules that are produced by bacteria, fungi and plants to gain an advantage over their competitors in challenging environments. Specialised metabolites, also referred to as secondary metabolites or natural products, exhibit a wide variety of biological activities, including many that are useful for pharmaceutical and agricultural applications, e.g. antibiotics, anti-cancer drugs, pesticides and herbicides. The production of specialised metabolites is typically encoded by biosynthetic gene clusters (BGCs): groups of co-localised and co-regulated genes that jointly encode a biosynthetic pathway. Therefore, microbial and plant genomes can be mined for novel specialised metabolite production by detecting BGCs and predicting their encoded products and functions. Similar to how the relationship between DNA, mRNA and protein describes the flow of information in cells, we can define a ‘central dogma’ of specialised metabolism: a BGC sequence encodes a set of enzymes, which together assemble a compound structure (or a cocktail of structural analogues), which in turn dictates specialised metabolite function. Understanding how information is translated from sequence to structure to function is key to natural product discovery. To address the first stage, sequence information, various tools have been developed that automatically detect BGCs from DNA sequence, including antiSMASH and its siblings fungiSMASH and plantiSMASH (1,2), GECCO (3), DeepBGC (4), RiPPMiner (5) and PRISM 4 (6). To facilitate dereplication and comparative analysis of predicted BGCs with known BGCs, and to characterise the interplay between sequence, structure and function, standardised data annotation and storage are essential. To this purpose, we developed the Minimum Information about a Biosynthetic Gene cluster (MIBiG) standard and built a database which contains standardised entries for experimentally validated BGCs of known function (7,8). Each entry minimally contains information about the nucleotide entry and coordinates of the genomic locus involved, the producing organism's taxonomy, biosynthetic class, name of the produced compound(s), and literature reference(s). There are also various optional fields for non-minimal entries, including fields for gene function, product structure and bioactivity, crosslinks to chemical structure databases such as NP Atlas (9) and PubChem (10), and monomer identity. With MIBiG 2.0 containing over 2000 entries, the database has become an important reference for many researchers that mine genomes for natural products. For example, it has been used to estimate the potential for biosynthetic novelty in large-scale microbiome studies (11,12), to identify conserved amino acids playing key roles in catalytic activities across enzyme families (13), to help guide natural product discovery efforts towards high-potential taxa (14), and to train machine-learning algorithms for natural product activity prediction (15). Here, we present MIBiG 3.0: an update designed to increase the number of non-minimal entries in our database and adding new data entries through a large-scale community annotation effort. We focused on three features: the characterisation and cross-linking of 1188 chemical structures, the annotation of 1002 bioactivities of BGC products, and the validation and annotation of 2020 protein domain substrates of nonribosomal peptide synthetases (NRPSs). In addition, we added 661 novel BGCs to the MIBiG database which were published since the last database update and removed 69 duplicate and low-quality entries (Figure 1). Together, these additions keep the database current, and provide unique opportunities for exploring complex sequence-structure-function relationships in diverse natural product domains. [Figure: Overview of MIBiG 3.0. (A) Added, removed and updated entries since MIBiG 2.0. (B) Improvements in the annotation of compounds, bioactivities, molecular targets and NRPS domain substrates.] METHODS AND IMPLEMENTATION Manual curation through crowdsourcing and mass online ‘annotathons’ As authors themselves typically have the best understanding of the BGC they have studied, we greatly encourage natural product researchers to submit their BGCs to MIBiG during the process of publishing their work. To this purpose, MIBiG supplies an online form through which researchers can request a unique MIBiG identifier and submit their experimentally verified BGCs, pre- or post-publication. Since MIBiG version 2.0, this has yielded 97 manually submitted, high-quality entries which have now been incorporated into MIBiG 3.0. Still, there are far more published BGCs that are not manually submitted to MIBiG. With an increasing number of papers describing novel BGCs being published every year, manually annotating, validating and adding BGCs to MIBiG has become a mammoth task. Therefore, we took to social media to gauge the community's interest in participating in an online annotation event. We received many positive responses, with 86 people from four different continents volunteering to participate in our MIBiG ‘annotathons’. We organised eight three-hour online sessions, accommodating different time-zones, with various breakout rooms dedicated to specific annotation tasks: annotating new clusters, annotating and cross-linking compound structures, annotating compound bioactivities, and assigning substrate selectivities to NRPS protein domains. We prepared multiple instruction videos and assigned an expert to each of the breakout rooms who could be directly approached with questions from annotators to ensure that annotation quality was consistent. In addition, one of our annotators at the CINVESTAV research institute mobilised fourteen MSc Integrative Biology students of their 2021 Bacterial Genomics class to annotate compound bioactivities under supervision. Finally, we resolved 125 database issues that were raised by users on our GitHub page, redefining BGC boundaries, correcting biosynthetic classes, adding and removing literature references, fixing compound structures, and removing duplicate entries. Annotating and cross-linking compound structures Since version 2.0, compound structures in MIBiG have been cross-linked to the NP Atlas database: a database containing structures of natural products isolated from bacteria and fungi. During the preparations for version 3.0, we collaborated with the NP Atlas team to (i) add structures for compounds in SMILES format (16), including stereochemical information where possible and (ii) cross-link them to five databases of chemical structures: NP Atlas (9), PubChem, ChemSpider (17), LOTUS (18), and ChEMBL (19). If compound entries were found in